Siegel RL, et al. Colorectal cancer statistics, 2023. CA Cancer J Clin. 2023;73(3):233–54.
Baidoun F, et al. Colorectal cancer epidemiology: recent trends and impact on outcomes. Curr Drug Targets. 2021;22(9):998–1009.
Article CAS PubMed Google Scholar
Hong Y, et al. Clinical study of colorectal cancer operation: survival analysis. Korean J Clin Oncol. 2020;16(1):3–8.
Article PubMed PubMed Central Google Scholar
Roshandel G, Ghasemi-Kebria F, Malekzadeh R. Colorectal cancer: epidemiology, risk factors, and prevention. Cancers (Basel). 2024. https://doi.org/10.3390/cancers16081530.
Yang W, et al. Current status and prospect of immunotherapy for colorectal cancer. Int J Colorectal Dis. 2023;38(1):266.
Meng R, et al. The potential role of gut microbiota outer membrane vesicles in colorectal cancer. Front Microbiol. 2023;14:1270158.
Article PubMed PubMed Central Google Scholar
Jung G, et al. Epigenetics of colorectal cancer: biomarker and therapeutic potential. Nat Rev Gastroenterol Hepatol. 2020;17(2):111–30.
Article PubMed PubMed Central Google Scholar
Chen B, et al. Targeting non-coding RNAs to overcome cancer therapy resistance. Signal Transduct Target Ther. 2022;7(1):121.
Article CAS PubMed PubMed Central Google Scholar
Bedoui S, Herold MJ, Strasser A. Emerging connectivity of programmed cell death pathways and its physiological implications. Nat Rev Mol Cell Biol. 2020;21(11):678–95.
Article CAS PubMed Google Scholar
Luo Y, et al. Non-coding RNAs in breast cancer: Implications for programmed cell death. Cancer Lett. 2022;550: 215929.
Article CAS PubMed Google Scholar
Wang LY, et al. The romantic history of signaling pathway discovery in cell death: an updated review. Mol Cell Biochem. 2023. https://doi.org/10.1007/s11010-023-04873-2.
Article PubMed PubMed Central Google Scholar
Chen W, et al. Clinical significance of non-coding RNA regulation of programmed cell death in hepatocellular carcinoma. Cancers (Basel). 2023. https://doi.org/10.3390/cancers15164187.
Article PubMed PubMed Central Google Scholar
Kaikkonen MU, Lam MT, Glass CK. Non-coding RNAs as regulators of gene expression and epigenetics. Cardiovasc Res. 2011;90(3):430–40.
Article CAS PubMed PubMed Central Google Scholar
Liu Y, et al. Non-coding RNAs in lung cancer: molecular mechanisms and clinical applications. Front Oncol. 2023;13:1256537.
Article CAS PubMed PubMed Central Google Scholar
Zhou X, et al. Non-coding RNA in cancer drug resistance: underlying mechanisms and clinical applications. Front Oncol. 2022;12: 951864.
Article CAS PubMed PubMed Central Google Scholar
Weledji E. The etiology and pathogenesis of colorectal cancer. Clin Oncol. 2024;9:2046.
Kedrin D, Gala MK. Genetics of the serrated pathway to colorectal cancer. Clin Transl Gastroenterol. 2015;6(4): e84.
Article CAS PubMed PubMed Central Google Scholar
Nguyen LH, Goel A, Chung DC. Pathways of colorectal carcinogenesis. Gastroenterology. 2020;158(2):291–302.
Article CAS PubMed Google Scholar
Malki A, et al. Molecular mechanisms of colon cancer progression and metastasis: recent insights and advancements. Int J Mol Sci. 2020. https://doi.org/10.3390/ijms22010130.
Article PubMed PubMed Central Google Scholar
Teimoorian F, et al. Association of Helicobacter pylori infection with colon cancer and adenomatous polyps. Iran J Pathol. 2018;13(3):325–32.
PubMed PubMed Central Google Scholar
Wang R, Leong RW. Primary sclerosing cholangitis as an independent risk factor for colorectal cancer in the context of inflammatory bowel disease: a review of the literature. World J Gastroenterol. 2014;20(27):8783–9.
Article PubMed PubMed Central Google Scholar
Redston MS, et al. Common occurrence of APC and K-ras gene mutations in the spectrum of colitis-associated neoplasias. Gastroenterology. 1995;108(2):383–92.
Article CAS PubMed Google Scholar
Hussain SP, et al. Increased p53 mutation load in noncancerous colon tissue from ulcerative colitis: a cancer-prone chronic inflammatory disease. Cancer Res. 2000;60(13):3333–7.
Brentnall TA, et al. A germline substitution in the human MSH2 gene is associated with high-grade dysplasia and cancer in ulcerative colitis. Gastroenterology. 1995;109(1):151–5.
Article CAS PubMed Google Scholar
Vogelstein B, et al. Genetic alterations during colorectal-tumor development. N Engl J Med. 1988;319(9):525–32.
Article CAS PubMed Google Scholar
Jass JR. Hyperplastic polyps and colorectal cancer: is there a link? Clin Gastroenterol Hepatol. 2004;2(1):1–8.
Goldstein NS. Serrated pathway and APC (conventional)-type colorectal polyps: molecular-morphologic correlations, genetic pathways, and implications for classification. Am J Clin Pathol. 2006;125(1):146–53.
Article CAS PubMed Google Scholar
Bettington M, et al. The serrated pathway to colorectal carcinoma: current concepts and challenges. Histopathology. 2013;62(3):367–86.
Baker K, et al. Proximal versus distal hyperplastic polyps of the colorectum: different lesions or a biological spectrum? J Clin Pathol. 2004;57(10):1089–93.
Article CAS PubMed PubMed Central Google Scholar
Noffsinger AE. Serrated polyps and colorectal cancer: new pathway to malignancy. Annu Rev Pathol. 2009;4:343–64.
Article CAS PubMed Google Scholar
Burnett-Hartman AN, et al. Genomic aberrations occurring in subsets of serrated colorectal lesions but not conventional adenomas. Cancer Res. 2013;73(9):2863–72.
Article CAS PubMed Google Scholar
Wang J, et al. ncRNA-encoded peptides or proteins and cancer. Mol Ther. 2019;27(10):1718–25.
Article CAS PubMed PubMed Central Google Scholar
Vos PD, et al. Modulation of miRNA function by natural and synthetic RNA-binding proteins in cancer. Cell Mol Life Sci. 2019;76(19):3745–52.
留言 (0)